New Seeking Alpha write up | AXSM Message Board Posts


Axsome Therapeutics, Inc.

  AXSM website

AXSM   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  1657 of 1772  at  11/27/2023 11:02:16 AM  by

Patc


New Seeking Alpha write up

Axsome Therapeutics: Positive Q3, We Like The Launch Success Story

Nov 27, 2023 10:41 AM | Axsome Therapeutics, Inc.(AXSM) | By: BiotechValley Insights

Axsome Therapeutics reports robust Q3 earnings with record revenue of $57.8 million, driven by sales of flagship product Auvelity.
The company plans to expand its sales force to deepen market penetration and reach a broader base of prescribers and patients.
Axsome's diversified portfolio and strategic positioning in the specialty pharmaceutical market position it well for sustained growth.
We maintain a buy rating on AXSM.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 5  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...